Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a "me too" drug?
about
Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a "me too" drug?
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Evolution of regorafenib from ...... ion or merely a "me too" drug?
@en
Evolution of regorafenib from ...... ion or merely a "me too" drug?
@nl
type
label
Evolution of regorafenib from ...... ion or merely a "me too" drug?
@en
Evolution of regorafenib from ...... ion or merely a "me too" drug?
@nl
prefLabel
Evolution of regorafenib from ...... ion or merely a "me too" drug?
@en
Evolution of regorafenib from ...... ion or merely a "me too" drug?
@nl
P2860
P356
P1476
Evolution of regorafenib from ...... ion or merely a "me too" drug?
@en
P2093
Gaurav Goel
P2860
P304
P356
10.2147/CMAR.S88825
P407
P577
2018-03-06T00:00:00Z